Aim Immunotech INC Form 4 insider transactions

AMEX

18 Mar 2024

AIM

Form 4: AIM ImmunoTech CEO Thomas Equels Acquires 75,758 Shares of Common Stock

AIM ImmunoTech's CEO and President, Thomas K Equels, purchased 75,758 shares of common stock at $0.33 per share on March 15, 2024.

AMEX

18 Mar 2024

AIM

Aim Immunotech INC

Form 4: AIM ImmunoTech COO Peter Rodino III Acquires Shares in Open Market

Peter Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., purchased 37,879 shares of common stock at $0.33 per share on March 15, 2024.